Marketing and R&D Strategies for Biotechnology Firms in the USA

Document Type

Article

Publication Date

1-1-1989

Abstract

This paper reports on a survey of 64 biotechnology firms in the USA about their R&D strategy, marketing focus and sources of technology. The survey explored the interrelationships among the strategic issues and how they were related with the means of appropriating R&D results. Three strategic clusters for technology acquisition emerged from the data: (i) internal developer, (ii) joint developer, and (iii) cooperative financed. Three marketing clusters were: (i) market penetrator, (ii) innovative marketer, and (iii) market developer. The R&D clusters were: (i) defensive strategy, (ii) aggressive strategy, and (iii) research-intensive strategy. External sources of technology appeared to be predominant among the various firms and apparently marketing strategy and source of technology had no significant relationship. Most of the firms were involved with commercial innovation in their R&D strategy and few were research specialists. Innovative firms were inclined to depend on external sources of technology. Issues related to appropriability of R&D results for the different groups have been examined for their implications for public policy. © 1989, Taylor & Francis Group, LLC. All rights reserved.

Identifier

0009668821 (Scopus)

Publication Title

Technology Analysis Strategic Management

External Full Text Location

https://doi.org/10.1080/09537328908523981

e-ISSN

14653990

ISSN

09537325

First Page

357

Last Page

367

Issue

4

Volume

1

Grant

SRS8705158

Fund Ref

National Science Foundation

This document is currently not available here.

Share

COinS